Quantbot Technologies LP Purchases New Position in The Chemours Company $CC

Key Points

• Quantbot Technologies LP purchased a new stake in The Chemours Company, acquiring 43,680 shares valued at approximately $591,000 during the first quarter.
• Several analytical firms have downgraded Chemours' stock price targets, with UBS reducing its target from $18.00 to $17.00, while Barclays lowered it from $16.00 to $13.00.
• Chemours has announced a quarterly dividend of $0.0875 per share, reflecting an annualized yield of 2.3%, despite having a negative payout ratio of -12.50%.

Quantbot Technologies LP purchased a new stake in The Chemours Company (NYSE:CC - Free Report) during the first quarter, according to its most recent filing with the SEC. The firm purchased 43,680 shares of the specialty chemicals company's stock, valued at approximately $591,000.

A number of other institutional investors have also recently made changes to their positions in CC. Vanguard Group Inc. boosted its position in shares of Chemours by 8.3% in the 1st quarter. Vanguard Group Inc. now owns 16,487,008 shares of the specialty chemicals company's stock worth $223,069,000 after purchasing an additional 1,263,047 shares in the last quarter. Ameriprise Financial Inc. boosted its position in shares of Chemours by 23.8% in the 4th quarter. Ameriprise Financial Inc. now owns 4,373,172 shares of the specialty chemicals company's stock worth $73,907,000 after purchasing an additional 839,849 shares in the last quarter. Millennium Management LLC boosted its position in shares of Chemours by 44.6% in the 4th quarter. Millennium Management LLC now owns 2,507,262 shares of the specialty chemicals company's stock worth $42,373,000 after purchasing an additional 773,537 shares in the last quarter. Public Sector Pension Investment Board acquired a new stake in shares of Chemours in the 1st quarter worth $6,411,000. Finally, Balyasny Asset Management L.P. boosted its position in shares of Chemours by 90.9% in the 4th quarter. Balyasny Asset Management L.P. now owns 935,031 shares of the specialty chemicals company's stock worth $15,802,000 after purchasing an additional 445,335 shares in the last quarter. Institutional investors and hedge funds own 76.26% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on CC. The Goldman Sachs Group lowered their price objective on Chemours from $21.00 to $14.00 and set a "neutral" rating for the company in a research report on Wednesday, May 14th. Wall Street Zen cut Chemours from a "hold" rating to a "sell" rating in a research report on Wednesday, May 21st. Barclays lowered their price objective on Chemours from $16.00 to $13.00 and set an "equal weight" rating for the company in a research report on Wednesday, May 28th. Morgan Stanley lowered their price target on Chemours from $22.00 to $15.00 and set an "equal weight" rating for the company in a research report on Monday, May 12th. Finally, Zacks Research raised Chemours from a "strong sell" rating to a "hold" rating in a research report on Wednesday. Five analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. Based on data from MarketBeat, Chemours has an average rating of "Moderate Buy" and an average target price of $17.38.

Insider Transactions at Chemours

In related news, insider Damian Gumpel acquired 13,400 shares of Chemours stock in a transaction on Monday, June 2nd. The stock was acquired at an average price of $9.22 per share, for a total transaction of $123,548.00. Following the purchase, the insider owned 123,879 shares of the company's stock, valued at approximately $1,142,164.38. This represents a 12.13% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Denise Dignam acquired 4,068 shares of Chemours stock in a transaction on Friday, August 8th. The shares were bought at an average price of $12.06 per share, with a total value of $49,060.08. Following the purchase, the chief executive officer directly owned 191,546 shares in the company, valued at approximately $2,310,044.76. The trade was a 2.17% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired a total of 25,290 shares of company stock valued at $250,437 in the last quarter. Company insiders own 0.34% of the company's stock.

Chemours Stock Performance

CC traded up $0.31 on Friday, reaching $15.38. 2,896,747 shares of the stock were exchanged, compared to its average volume of 4,114,616. The company's 50-day moving average price is $13.33 and its 200 day moving average price is $12.78. The Chemours Company has a fifty-two week low of $9.13 and a fifty-two week high of $22.38. The company has a debt-to-equity ratio of 17.16, a current ratio of 1.68 and a quick ratio of 0.83. The firm has a market capitalization of $2.30 billion, a PE ratio of -5.49 and a beta of 1.61.

Chemours (NYSE:CC - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The specialty chemicals company reported $0.58 earnings per share for the quarter, beating analysts' consensus estimates of $0.46 by $0.12. The business had revenue of $1.62 billion during the quarter, compared to analyst estimates of $1.57 billion. Chemours had a positive return on equity of 35.14% and a negative net margin of 7.19%.The company's revenue was up 5.0% on a year-over-year basis. During the same quarter last year, the business posted $0.38 EPS. Chemours has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, sell-side analysts forecast that The Chemours Company will post 2.03 EPS for the current fiscal year.

Chemours Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 12th. Shareholders of record on Friday, August 15th will be paid a dividend of $0.0875 per share. The ex-dividend date is Friday, August 15th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 2.3%. Chemours's dividend payout ratio (DPR) is presently -12.50%.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.